...
首页> 外文期刊>Molecular Immunology >Pulmonary surfactant phosphatidylcholines induce immunological adaptation of alveolar macrophages
【24h】

Pulmonary surfactant phosphatidylcholines induce immunological adaptation of alveolar macrophages

机译:肺表面活性剂磷脂酰胆碱诱导肺泡巨噬细胞的免疫学适应

获取原文
获取原文并翻译 | 示例
           

摘要

Pulmonary surfactant plays an important role in lung surface tension, defense against invading pathogens, and immune response. Furthermore, alveolar macrophages (AM) that comprise the front line of immune defense against inhaled microorganisms are covered by a layer of pulmonary fluid. Phosphatidylcholines (PCs), including unsaturated lipids such as 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), are the most prevalent phospholipids in pulmonary surfactant. POPC reacts with ozone to produce 1-palmitoyl-2-(9-oxononanoyl)-sn-glycero-3-phosphocholine (PONPC), a soluble mediator that initiates an inflammatory reaction in the lungs. However, the modulatory effects of POPC and PONPC on biology and activity of AM remain inconclusive. The exposure of AM (cell line AMJ2-C11) to POPC and PONPC was not directly related to the production of inflammatory mediators. However, AM, pre-incubated with POPC or PONPC, showed enhanced response after lipopolysaccharide (LPS) stimulation, and increased the production of nitric oxide and cytokines. This phenomenon was also observed for classical-polarized macrophages (M1). This increment on the production of inflammatory mediators was not associated with macrophage polarization, but with up-regulation of Tlr4 and Myd88 gene expression, which was in accordance with the adaptation of immune cells. This observation was confirmed by the histone acetylation epigenetic pathway. In contrast to the priming effect of POPC on AM activity, a harmful immune response, induced on incubation with PONPC, improved prostaglandin E-2 (PGE(2)) formation, resulting in diminished bacterial phagocytosis. Additionally, PONPC induced production of CXCL1/KC, which potentially mediates neutrophil recruitment and enhances tissue inflammation. These results disclosed another dynamic mechanism by which pulmonary surfactant lipids (natural or oxidized) primed macrophage activity, thus affecting lung host defense.
机译:肺表面活性剂在肺表面张力下起重要作用,防御侵袭病原体和免疫应答。此外,包含对吸入微生物的免疫防护前线的肺泡巨噬细胞(AM)被一层肺液覆盖。磷脂酰胆碱(PCS),包括不饱和脂质,如1-palmitoyl-2-Oleyoyl-sn-甘油-3-磷光啉(PoPc),是肺表面活性剂中最普遍的磷脂。 POPC与臭氧反应以产生1-palmItoyl-2-(9-氧代苯甲酰)-sn-甘油-3-磷光啉(PONPC),是在肺中引发炎症反应的可溶性介体。然而,POPC和PONPC对生物学和活动的调节效果仍然不确定。 am(细胞系AMJ2-C11)暴露于POPC和PONPC与炎症介质的产生没有直接相关。然而,与PoPC或PONPC预孵育的AM显示在脂多糖(LPS)刺激后的增强响应,并增加了一氧化氮和细胞因子的产生。还观察到这种现象用于典型偏振巨噬细胞(M1)。这种炎症介质的生产的增量与巨噬细胞极化无关,但随着TLR4和MyD88基因表达的上调,符合免疫细胞的适应。通过组蛋白乙酰化表观遗传途径确认该观察结果。与POPC对AM活性的启动作用相比,诱导与PONPC孵育的有害免疫应答,改善前列腺素E-2(PGE(2))形成,导致细菌吞噬作用枯萎病。此外,PONPC诱导CXCL1 / KC的产生,其中潜在地介导中性粒细胞募集并增强组织炎症。这些结果公开了另一种动态机制,其肺表面活性剂脂质(天然或氧化)巨噬细胞活性,从而影响肺宿主防御。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号